Skip to main content
. 2017 Mar 28;2017(3):CD011648. doi: 10.1002/14651858.CD011648.pub2

ChiCTR‐IPR‐16008935.

Trial name or title Biochemical Response of PBC‐AIH Overlap Syndrome Induced by Ursodeoxycholic Acid Only or Combination Therapy of Immunosuppressive Agents
Methods Randomised parallel clinical trial
Participants People with primary biliary cholangitis and autoimmune hepatitis overlap syndrome.
Interventions Group 1: UDCA + immunosuppression
Further details: not provided.
Group 2: UDCA.
Further details: not provided.
Outcomes Adverse events
Starting date Not stated.
Contact information yangli_hx@scu.edu.cn
Notes Status: recruiting.